Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Thorstensson

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
AIDS Research and Human Retroviruses|March 31, 1998
Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strainsG E Corrigan, L Al-Khalili, A Malmsten, et al.
AIDS (London, England)|December 24, 1998
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsmC Nilsson, B Mäkitalo, R Thorstensson, et al.
Clinical and Experimental Immunology|February 26, 2005
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-BissauS Andersson, O Larsen, Z Da Silva, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 1, 2004
Ethical issues in research on control of the HIV/AIDS epidemic: report from a workshop of the world federation of scientists, Erice, Sicily, Italy, 22-24 August 2003G de Thé, F Buonaguro, N Charpak, et al.
Journal of Acquired Immune Deficiency Syndromes|June 1, 1994
Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccineP Putkonen, E Björling, L Akerblom, et al.
AIDS (London, England)|November 23, 2000
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study GroupS Lindbäck, R Thorstensson, A C Karlsson, et al.
Nature Medicine|September 1, 1995
Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccineP Putkonen, L Walther, Y J Zhang, et al.
Scandinavian Journal of Immunology|January 13, 2005
Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individualsR K S Ahmed, H Norrgren, Z da Silva, et al.
Journal of Medical Virology|May 1, 1991
HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variablesM Neumüller, A Karlsson, J Lennerstrand, et al.
Journal of Virology|February 11, 1999
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usageA Mörner, A Björndal, J Albert, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
AIDS Research and Human Retroviruses|March 31, 1998
Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strainsG E Corrigan, L Al-Khalili, A Malmsten, et al.
AIDS (London, England)|December 24, 1998
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsmC Nilsson, B Mäkitalo, R Thorstensson, et al.
Clinical and Experimental Immunology|February 26, 2005
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-BissauS Andersson, O Larsen, Z Da Silva, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 1, 2004
Ethical issues in research on control of the HIV/AIDS epidemic: report from a workshop of the world federation of scientists, Erice, Sicily, Italy, 22-24 August 2003G de Thé, F Buonaguro, N Charpak, et al.
Journal of Acquired Immune Deficiency Syndromes|June 1, 1994
Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccineP Putkonen, E Björling, L Akerblom, et al.
AIDS (London, England)|November 23, 2000
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study GroupS Lindbäck, R Thorstensson, A C Karlsson, et al.
Nature Medicine|September 1, 1995
Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccineP Putkonen, L Walther, Y J Zhang, et al.
Scandinavian Journal of Immunology|January 13, 2005
Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individualsR K S Ahmed, H Norrgren, Z da Silva, et al.
Journal of Medical Virology|May 1, 1991
HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variablesM Neumüller, A Karlsson, J Lennerstrand, et al.
Journal of Virology|February 11, 1999
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usageA Mörner, A Björndal, J Albert, et al.
Pageof 8